Skip to main content
. 2009 Sep;175(3):940–946. doi: 10.2353/ajpath.2009.081094

Figure 3.

Figure 3

Kaplan-Meier survival graph for estrogen receptor-negative early-stage IDC. Overall survival according to the presence (scores 1, 2, and 3) or absence (score 0) of TIMP-4 in tumors on the TMA for patients with estrogen receptor-negative early-stage IDC (N = 156) (log-rank P = 0.0011).